1921
Volume 83, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

We compare, contrast, and evaluate methods to quantify genetic markers of antimalarial drug resistance. Frequency estimates should be reported along with crude prevalence. There are four main potential methods to estimate frequencies in blood samples: simple counting of single nucleotide polymorphisms (SNPs) and haplotypes in samples with multiplicity of infection (MOI) = 1; SNP counting in samples with MOI ≤ 2; SNP and haplotypes counting in samples with unambiguous genotypes; statistical inference using SNP and MOI data from all samples. Large differences between the methods became apparent when analyzing field data with high MOI. Simple counting dramatically reduced sample size and estimate precision, and we show that analysis of unambiguous samples is biased, leaving maximum likelihood or similar statistical inference as the only practical option. It is essential to account for genotyping missing minor clones; ignoring this phenomenon resulted in a 2-fold underestimation of SNPs and haplotypes present at low frequencies.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.2010.10-0072
2010-09-07
2019-05-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/83/3/489.html?itemId=/content/journals/10.4269/ajtmh.2010.10-0072&mimeType=html&fmt=ahah

References

  1. Picot S, Olliaro P, De Monbrison F, Bienvenu AL, Price RN, Ringwald P, , 2009. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J 8: 89.[Crossref] [Google Scholar]
  2. Laufer MK, Djimde AA, Plowe CV, , 2007. Monitoring and deterring drug-resistant malaria in the era of combination therapy. Am J Trop Med Hyg 77: 160169. [Google Scholar]
  3. Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA, Rosenthal PJ, , 2007. World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. Malar J 6: 121.[Crossref] [Google Scholar]
  4. Liu SF, Mu JB, Jiang HY, Su XZ, , 2008. Effects of Plasmodium falciparum mixed infections on in vitro antimalarial drug tests and genotyping. Am J Trop Med Hyg 79: 178184. [Google Scholar]
  5. Juliano JJ, Trottman P, Mwapasa V, Meshnick SR, , 2008. Short report: detection of the dihydrofolate reductase-164L mutation in Plasmodium falciparum infections from Malawi by heteroduplex tracking assay. Am J Trop Med Hyg 78: 892894. [Google Scholar]
  6. Farnert A, Arez AP, Babiker HA, Beck HP, Benito A, Bjorkman A, Bruce MC, Conway DJ, Day KP, Henning L, Mercereau-Puijalon O, Ranford-Cartwright LC, Rubio JM, Snounou G, Walliker D, Zwetyenga J, do Rosario VE, , 2001. Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans R Soc Trop Med Hyg 95: 225232.[Crossref] [Google Scholar]
  7. Alonso PL, Smith T, Armstrong Schellenberg JRM, Masanja H, Mwankusye S, Urassa H, Bastos de Azevedo I, Chongela J, Kobero S, Menendez C, Hurt N, Thomas MC, Lyimo E, Weiss NA, Hayes R, Kitua AY, Lopez MC, Kilama WL, Teuscher T, Tanner M, , 1994. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 344: 11751181.[Crossref] [Google Scholar]
  8. Nsanzabana C, , 2008. Dynamics of Malaria Parasite Resistance Markers in Two Areas of Different Transmission Intensity. PhD thesis: University of Neuchatal, Switzerland. [Google Scholar]
  9. Nsanzabana C, Hastings IM, Marfurt J, Muller I, Baea K, Rare L, Schapira A, Felger I, Betschart B, Smith TA, Beck HP, Genton B, , 2010. Quantifying the evolution and impact of antimalarial drug resistance: drug use, spread of resistance and drug failure over a 12 year period in Papua New Guinea. J Infect Dis 201: 435443.[Crossref] [Google Scholar]
  10. Hartl DL, Clark AG, , 2007. Principles of Population Genetics. Fourth edition. Sunderland, MA: Sinauer Associates. [Google Scholar]
  11. Newcombe RG, , 1998. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17: 857872.[Crossref] [Google Scholar]
  12. Williams BG, Dye C, , 1994. Maximum likelihood for parasitologists. Parasitol Today 10: 489493.[Crossref] [Google Scholar]
  13. Hastings IM, Smith TA, , 2008. MalHaploFreq: a computer programme for estimating malaria haplotype frequencies from blood samples. Malar J 7: 130.[Crossref] [Google Scholar]
  14. Hill WG, Babiker HA, , 1995. Estimation of numbers of malaria clones in blood samples. Proc R Soc Lond B Biol Sci 262: 249257.[Crossref] [Google Scholar]
  15. Alifrangis M, Lemnge MM, Ronn AM, Segeja MD, Magesa SM, Khalil IF, Bygbjerg IC, , 2003. Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets. Am J Trop Med Hyg 69: 238243. [Google Scholar]
  16. Zimmerman PA, , 2003. Roll back of Plasmodium falciparum antifolate resistance by insecticide-treated nets. Am J Trop Med Hyg 69: 236237. [Google Scholar]
  17. Mharakurwa S, Mutambu SL, Mudyiradima R, Chimbadzwa T, Chandiwana SK, Day KP, , 2004. Association of house spraying with suppressed levels of drug resistance in Zimbabwe. Malar J 3: 35.[Crossref] [Google Scholar]
  18. Anderson TJC, Nair S, Sudimack D, Williams JT, Mayxay M, Newton PN, Guthmann JP, Smithuis FM, Hien TT, Van den Broek IVF, White NJ, Nosten F, , 2005. Geographical distribution of selected and putatively neutral SNPs in southeast Asian malaria parasites. Mol Biol Evol 22: 23622374.[Crossref] [Google Scholar]
  19. Schoepflin S, Marfurt J, Goroti M, Baisor M, Mueller I, Felger I, , 2008. Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population. Malar J 7: 78.[Crossref] [Google Scholar]
  20. Hastings IM, Watkins WM, , 2006. Tolerance is the key to understanding antimalarial drug resistance. Trends Parasitol 22: 7177.[Crossref] [Google Scholar]
  21. Sisowath C, Stromberg J, Martensson A, Msellem M, Obondo C, Bjorkman A, Gill JP, , 2005. In vivo selection of Plasmodium falciparum pfmdr 1 86N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis 191: 10141017.[Crossref] [Google Scholar]
  22. Watkins WM, Mosobo M, , 1993. Treatment of Plasmodium falciparum malaria with pyrimethamine-sulphadoxine: selective pressure for resistance is a function of long half-life. Trans R Soc Trop Med Hyg 87: 7578.[Crossref] [Google Scholar]
  23. Juliano J, Randrianarivelojosia M, Ramarosandratana B, Ariey F, Mwapasa V, Meshnick S, , 2009. Nonradioactive heteroduplex tracking assay for the detection of minority-variant chloroquine-resistant Plasmodium falciparum in Madagascar. Malar J 8: 47.[Crossref] [Google Scholar]
  24. Sibley CH, Hyde JE, Sims PFG, Plowe CV, Kublin JG, Mberu EK, Cowman AF, Winstanley PA, Watkins WM, Nzila AM, , 2001. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol 17: 582588.[Crossref] [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2010.10-0072
Loading
/content/journals/10.4269/ajtmh.2010.10-0072
Loading

Data & Media loading...

Supplementary appendix

  • Received : 02 Feb 2010
  • Accepted : 19 May 2010
  • Published online : 07 Sep 2010

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error